Table 3.

Response Rates by Histologic Subtype for Patients With Locally Advanced Nonmelanoma Cutaneous Malignant Neoplasms After an ILI

Patients With Evaluable Response at 3 mo	Per Infusion, %	Per Patient, %	Last Known Status
With soft-tissue sarcomas (12 patients, 14 infusions)			7 NED, alive; 2 SD, alive; 2 SD, died of metastatic disease; 1 progressive disease
Overall response rate	78	75
Complete response rate	14	17
Partial response rate	64	58
With Merkel and squamous cell carcinoma (8 patients, 10 infusions)			2 NED, alive; 1 NED, died of other causes; 1 SD, alive; 1 SD, died of metastatic disease; 2 progressive disease, alive; 1 progressive disease, died of metastatic disease
Overall response rate	80	75
Complete response rate	30	25
Partial response rate	50	50

Abbreviations: NED, no evidence of disease; SD, stable disease.